nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—liver cancer	0.535	1	CbGaD
Fluphenazine—HTR2C—Sorafenib—liver cancer	0.0906	0.424	CbGbCtD
Fluphenazine—CYP1A2—Sorafenib—liver cancer	0.033	0.154	CbGbCtD
Fluphenazine—ABCB1—Sorafenib—liver cancer	0.0288	0.135	CbGbCtD
Fluphenazine—CYP2D6—Sorafenib—liver cancer	0.0272	0.127	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—liver cancer	0.0175	0.0819	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—liver cancer	0.0165	0.0772	CbGbCtD
Fluphenazine—Faecalith—Epirubicin—liver cancer	0.00219	0.0346	CcSEcCtD
Fluphenazine—Faecaloma—Epirubicin—liver cancer	0.00219	0.0346	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—liver cancer	0.00203	0.032	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—liver cancer	0.00203	0.032	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—liver cancer	0.00187	0.0296	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—liver cancer	0.00173	0.0274	CcSEcCtD
Fluphenazine—Gynaecomastia—Sorafenib—liver cancer	0.00151	0.024	CcSEcCtD
Fluphenazine—Eczema—Sorafenib—liver cancer	0.00137	0.0216	CcSEcCtD
Fluphenazine—Renal failure acute—Sorafenib—liver cancer	0.00133	0.021	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Sorafenib—liver cancer	0.0013	0.0206	CcSEcCtD
Fluphenazine—Dysphagia—Sorafenib—liver cancer	0.00106	0.0168	CcSEcCtD
Fluphenazine—Pneumonia—Sorafenib—liver cancer	0.000952	0.0151	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—liver cancer	0.000918	0.0145	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—liver cancer	0.000849	0.0134	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—liver cancer	0.000845	0.0134	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—liver cancer	0.000782	0.0124	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—liver cancer	0.000749	0.0118	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—liver cancer	0.000743	0.0118	CcSEcCtD
Fluphenazine—Erythema—Sorafenib—liver cancer	0.00074	0.0117	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—liver cancer	0.000712	0.0113	CcSEcCtD
Fluphenazine—Muscle spasms—Sorafenib—liver cancer	0.000711	0.0113	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—liver cancer	0.000693	0.011	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—liver cancer	0.000688	0.0109	CcSEcCtD
Fluphenazine—Angioedema—Sorafenib—liver cancer	0.000676	0.0107	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—liver cancer	0.000666	0.0105	CcSEcCtD
Fluphenazine—Leukopenia—Sorafenib—liver cancer	0.000662	0.0105	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—liver cancer	0.000659	0.0104	CcSEcCtD
Fluphenazine—Hypertension—Sorafenib—liver cancer	0.000639	0.0101	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—liver cancer	0.000626	0.00989	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—liver cancer	0.000618	0.00978	CcSEcCtD
Fluphenazine—Dry mouth—Sorafenib—liver cancer	0.000616	0.00974	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—liver cancer	0.000616	0.00974	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—liver cancer	0.000608	0.00961	CcSEcCtD
Fluphenazine—Anaphylactic shock—Sorafenib—liver cancer	0.000604	0.00955	CcSEcCtD
Fluphenazine—Skin disorder—Sorafenib—liver cancer	0.000587	0.00928	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—liver cancer	0.000579	0.00916	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—liver cancer	0.000572	0.00905	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—liver cancer	0.000562	0.00889	CcSEcCtD
Fluphenazine—Dyspnoea—Sorafenib—liver cancer	0.000538	0.00852	CcSEcCtD
Fluphenazine—Decreased appetite—Sorafenib—liver cancer	0.000525	0.0083	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—liver cancer	0.000517	0.00818	CcSEcCtD
Fluphenazine—Constipation—Sorafenib—liver cancer	0.000516	0.00817	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—liver cancer	0.000505	0.00799	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—liver cancer	0.000492	0.00778	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000481	0.00761	CcSEcCtD
Fluphenazine—Urticaria—Sorafenib—liver cancer	0.00048	0.00759	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—liver cancer	0.000479	0.00757	CcSEcCtD
Fluphenazine—Body temperature increased—Sorafenib—liver cancer	0.000477	0.00755	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000469	0.00742	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—liver cancer	0.000468	0.00739	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—liver cancer	0.000463	0.00733	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—liver cancer	0.000455	0.0072	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000445	0.00704	CcSEcCtD
Fluphenazine—Hypersensitivity—Sorafenib—liver cancer	0.000445	0.00704	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000434	0.00687	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—liver cancer	0.000432	0.00683	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—liver cancer	0.000429	0.00678	CcSEcCtD
Fluphenazine—Pruritus—Sorafenib—liver cancer	0.000427	0.00676	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—liver cancer	0.0004	0.00632	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—liver cancer	0.000392	0.00621	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—liver cancer	0.000392	0.00621	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—liver cancer	0.000389	0.00615	CcSEcCtD
Fluphenazine—Headache—Sorafenib—liver cancer	0.000378	0.00598	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—liver cancer	0.000373	0.0059	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000365	0.00577	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—liver cancer	0.000363	0.00574	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—liver cancer	0.000363	0.00574	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—liver cancer	0.00036	0.00569	CcSEcCtD
Fluphenazine—Nausea—Sorafenib—liver cancer	0.000359	0.00567	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—liver cancer	0.000358	0.00567	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—liver cancer	0.000352	0.00557	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—liver cancer	0.00035	0.00553	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—liver cancer	0.000345	0.00545	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000338	0.00534	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000331	0.00524	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—liver cancer	0.000327	0.00517	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—liver cancer	0.000326	0.00515	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—liver cancer	0.000324	0.00512	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—liver cancer	0.000309	0.00489	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—liver cancer	0.000302	0.00478	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—liver cancer	0.000286	0.00453	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—liver cancer	0.000273	0.00433	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—liver cancer	0.000263	0.00416	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—liver cancer	0.000258	0.00408	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—liver cancer	0.000253	0.004	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—liver cancer	0.000251	0.00397	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—liver cancer	0.000245	0.00387	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—liver cancer	0.000243	0.00385	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—liver cancer	0.000238	0.00377	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—liver cancer	0.000236	0.00373	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—liver cancer	0.000233	0.00368	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—liver cancer	0.000228	0.0036	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—liver cancer	0.000226	0.00358	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—liver cancer	0.000223	0.00353	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—liver cancer	0.000218	0.00346	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—liver cancer	0.000218	0.00345	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—liver cancer	0.000217	0.00343	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—liver cancer	0.000211	0.00333	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—liver cancer	0.000209	0.0033	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—liver cancer	0.000207	0.00327	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—liver cancer	0.000202	0.00319	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—liver cancer	0.000201	0.00317	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—liver cancer	0.000199	0.00315	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—liver cancer	0.000198	0.00314	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—liver cancer	0.000194	0.00307	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—liver cancer	0.000193	0.00305	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—liver cancer	0.000191	0.00302	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—liver cancer	0.000184	0.00291	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—liver cancer	0.000184	0.0029	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—liver cancer	0.00018	0.00284	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—liver cancer	0.000177	0.0028	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—liver cancer	0.000177	0.00279	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—liver cancer	0.000176	0.00279	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—liver cancer	0.000164	0.0026	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—liver cancer	0.000164	0.00259	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—liver cancer	0.000163	0.00258	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—liver cancer	0.000158	0.0025	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—liver cancer	0.000152	0.00241	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—liver cancer	0.000146	0.00231	CcSEcCtD
Fluphenazine—Headache—Epirubicin—liver cancer	0.00014	0.00221	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—liver cancer	0.000133	0.0021	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—liver cancer	0.000129	0.00205	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—liver cancer	0.000123	0.00194	CcSEcCtD
Fluphenazine—Thioridazine—CYP2E1—liver cancer	0.000116	0.165	CrCbGaD
Fluphenazine—Methotrimeprazine—CYP2E1—liver cancer	0.000111	0.157	CrCbGaD
Fluphenazine—Acepromazine—ALB—liver cancer	8.93e-05	0.126	CrCbGaD
Fluphenazine—Thioproperazine—ALB—liver cancer	8.73e-05	0.123	CrCbGaD
Fluphenazine—Thiothixene—ALB—liver cancer	8.59e-05	0.121	CrCbGaD
Fluphenazine—Pipotiazine—ALB—liver cancer	8.59e-05	0.121	CrCbGaD
Fluphenazine—Chlorpromazine—CYP2E1—liver cancer	8.48e-05	0.12	CrCbGaD
Fluphenazine—Chlorpromazine—ALB—liver cancer	4.66e-05	0.0658	CrCbGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—liver cancer	6.32e-06	3.37e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—liver cancer	6.3e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STAT3—liver cancer	6.29e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—JUN—liver cancer	6.29e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—liver cancer	6.29e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—liver cancer	6.28e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—liver cancer	6.28e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—JUN—liver cancer	6.27e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STAT3—liver cancer	6.26e-06	3.33e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—liver cancer	6.24e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—STAT3—liver cancer	6.23e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—STAT3—liver cancer	6.23e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—liver cancer	6.22e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—liver cancer	6.21e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—liver cancer	6.21e-06	3.3e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—liver cancer	6.2e-06	3.3e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CDKN1A—liver cancer	6.19e-06	3.3e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—liver cancer	6.12e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	6.11e-06	3.25e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—liver cancer	6.1e-06	3.25e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	6.09e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CDKN1A—liver cancer	6.08e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CD—liver cancer	6.07e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK8—liver cancer	6.04e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—liver cancer	6.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—liver cancer	6.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	6.01e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—liver cancer	6e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—liver cancer	5.99e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—liver cancer	5.99e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—RAF1—liver cancer	5.98e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—liver cancer	5.97e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK8—liver cancer	5.95e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	5.94e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—liver cancer	5.94e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK8—liver cancer	5.93e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—liver cancer	5.93e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—liver cancer	5.92e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—liver cancer	5.89e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—liver cancer	5.88e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—liver cancer	5.85e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—liver cancer	5.85e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MTOR—liver cancer	5.84e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—liver cancer	5.84e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—liver cancer	5.83e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—liver cancer	5.83e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—liver cancer	5.83e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—liver cancer	5.82e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—liver cancer	5.8e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—liver cancer	5.8e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—liver cancer	5.8e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—liver cancer	5.79e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—liver cancer	5.79e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RAF1—liver cancer	5.79e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RAF1—liver cancer	5.79e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.78e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—liver cancer	5.78e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—liver cancer	5.78e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—liver cancer	5.77e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—liver cancer	5.73e-06	3.05e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—liver cancer	5.72e-06	3.05e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—liver cancer	5.72e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—liver cancer	5.7e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	5.67e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—liver cancer	5.65e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—liver cancer	5.65e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—liver cancer	5.65e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—liver cancer	5.65e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—liver cancer	5.65e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—liver cancer	5.59e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—liver cancer	5.58e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—liver cancer	5.58e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—liver cancer	5.56e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	5.54e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—liver cancer	5.53e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—liver cancer	5.53e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—liver cancer	5.51e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—liver cancer	5.51e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—liver cancer	5.51e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—liver cancer	5.49e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—liver cancer	5.48e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—liver cancer	5.48e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—liver cancer	5.48e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—liver cancer	5.44e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—liver cancer	5.43e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	5.41e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—liver cancer	5.4e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	5.4e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—liver cancer	5.39e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—liver cancer	5.39e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—liver cancer	5.38e-06	2.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—liver cancer	5.37e-06	2.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—liver cancer	5.36e-06	2.86e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—liver cancer	5.35e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—liver cancer	5.35e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—liver cancer	5.34e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—liver cancer	5.34e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—liver cancer	5.33e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—liver cancer	5.33e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—liver cancer	5.32e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—liver cancer	5.3e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—liver cancer	5.3e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—liver cancer	5.29e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—liver cancer	5.27e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—liver cancer	5.23e-06	2.78e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—liver cancer	5.22e-06	2.78e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—liver cancer	5.2e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—liver cancer	5.2e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—liver cancer	5.19e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—liver cancer	5.19e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—liver cancer	5.18e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—liver cancer	5.16e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—liver cancer	5.16e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—liver cancer	5.13e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—liver cancer	5.12e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—liver cancer	5.11e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—liver cancer	5.09e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—liver cancer	5.08e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—liver cancer	5.08e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—liver cancer	5.06e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—liver cancer	5.06e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—liver cancer	5.06e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—liver cancer	5.05e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—liver cancer	5.05e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—liver cancer	5.05e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—liver cancer	5.04e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—liver cancer	5.04e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—liver cancer	5.04e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—liver cancer	5.03e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—liver cancer	5.01e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—liver cancer	5.01e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	5e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—liver cancer	4.99e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	4.96e-06	2.64e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—liver cancer	4.95e-06	2.63e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	4.94e-06	2.63e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK8—liver cancer	4.94e-06	2.63e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—liver cancer	4.93e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—liver cancer	4.93e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—liver cancer	4.92e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—liver cancer	4.92e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—liver cancer	4.92e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—liver cancer	4.91e-06	2.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—liver cancer	4.91e-06	2.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—liver cancer	4.89e-06	2.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—liver cancer	4.89e-06	2.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—liver cancer	4.88e-06	2.6e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—liver cancer	4.85e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—liver cancer	4.8e-06	2.56e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—liver cancer	4.79e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—liver cancer	4.78e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK8—liver cancer	4.78e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK8—liver cancer	4.78e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—liver cancer	4.76e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—liver cancer	4.76e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—liver cancer	4.74e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—liver cancer	4.72e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—liver cancer	4.72e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—liver cancer	4.72e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—liver cancer	4.7e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—liver cancer	4.67e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—liver cancer	4.67e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—liver cancer	4.66e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—liver cancer	4.65e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—liver cancer	4.6e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—liver cancer	4.59e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	4.59e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—liver cancer	4.57e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—liver cancer	4.56e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—liver cancer	4.55e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—liver cancer	4.55e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—liver cancer	4.51e-06	2.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—liver cancer	4.5e-06	2.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—liver cancer	4.5e-06	2.39e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—liver cancer	4.41e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—liver cancer	4.41e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—liver cancer	4.4e-06	2.34e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—liver cancer	4.37e-06	2.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—liver cancer	4.37e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—liver cancer	4.37e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—liver cancer	4.36e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—liver cancer	4.36e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—liver cancer	4.36e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—liver cancer	4.35e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—liver cancer	4.35e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	4.29e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—liver cancer	4.29e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—liver cancer	4.28e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—liver cancer	4.26e-06	2.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—liver cancer	4.25e-06	2.26e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—liver cancer	4.23e-06	2.25e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—liver cancer	4.22e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—liver cancer	4.19e-06	2.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—liver cancer	4.18e-06	2.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—liver cancer	4.15e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—liver cancer	4.15e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—liver cancer	4.14e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—liver cancer	4.12e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—liver cancer	4.12e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—liver cancer	4.06e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—liver cancer	4.06e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—liver cancer	4.06e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—liver cancer	4.05e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—liver cancer	4.05e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—liver cancer	4.03e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—liver cancer	4.03e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—liver cancer	4.02e-06	2.14e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—liver cancer	4.02e-06	2.14e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—liver cancer	3.97e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—liver cancer	3.96e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	3.9e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—liver cancer	3.88e-06	2.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—liver cancer	3.86e-06	2.05e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—liver cancer	3.81e-06	2.03e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—liver cancer	3.8e-06	2.02e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—liver cancer	3.79e-06	2.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—liver cancer	3.77e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—liver cancer	3.75e-06	2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—liver cancer	3.75e-06	2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—liver cancer	3.61e-06	1.92e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—liver cancer	3.56e-06	1.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—liver cancer	3.56e-06	1.9e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—liver cancer	3.5e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—liver cancer	3.5e-06	1.86e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—liver cancer	3.5e-06	1.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—liver cancer	3.48e-06	1.85e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—liver cancer	3.46e-06	1.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—liver cancer	3.44e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—liver cancer	3.44e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—liver cancer	3.44e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—liver cancer	3.36e-06	1.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—liver cancer	3.36e-06	1.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—liver cancer	3.33e-06	1.77e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—liver cancer	3.33e-06	1.77e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—liver cancer	3.29e-06	1.75e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—liver cancer	3.23e-06	1.72e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—liver cancer	3.19e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—liver cancer	3.19e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—liver cancer	3.19e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—liver cancer	3.15e-06	1.68e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—liver cancer	3.05e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—liver cancer	3.05e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—liver cancer	3.04e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—liver cancer	2.91e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—liver cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—liver cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—liver cancer	2.64e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.58e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—liver cancer	2.48e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—liver cancer	2.1e-06	1.12e-05	CbGpPWpGaD
